Combination strategy may optimize interferon-based therapy for chronic hepatitis B
Background and objectives Peginterferon-α treatment exhibits low rates of the serological conversion rate of hepatitis B e antigen…
Genetic modification enhances “living drugs” for blood cancers
CAR T cells are patient-derived, genetically engineered immune cells. They are “living drugs” and constitute a milestone in…
Concertgoers back detection dogs as practical COVID-19 screening tool in real-world trial
After experiencing canine COVID-19 screening at concerts, participants reported greater trust in detection dogs, positioning them as a…